SOMNOMED LTD.SOMNOMED LTD.SOMNOMED LTD.

SOMNOMED LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪26.52 M‬EUR
−0.056EUR
‪−4.88 M‬EUR
‪51.06 M‬EUR
‪171.66 M‬
Beta (1Y)
1.62

About SOMNOMED LIMITED

Headquarters
Sydney
Founded
1987
ISIN
AU000000SOM1
FIGI
BBG000R00P67
SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and Sunrise Sleep Test. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded in 2004 and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SOMNOMED LTD. stocks are traded under the ticker RJV.
SOMNOMED LTD. is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
RJV earnings for the last quarter are −0.03 EUR per share, whereas the estimation was −0.01 EUR resulting in a −239.50% surprise. The estimated earnings for the next quarter are −0.01 EUR per share. See more details about SOMNOMED LTD. earnings.
SOMNOMED LTD. revenue for the last quarter amounts to ‪27.82 M‬ EUR despite the estimated figure of ‪27.14 M‬ EUR. In the next quarter revenue is expected to reach ‪26.63 M‬ EUR.
Yes, you can track SOMNOMED LTD. financials in yearly and quarterly reports right on TradingView.
RJV net income for the last quarter is ‪−3.91 M‬ EUR, while the quarter before that showed ‪−2.60 M‬ EUR of net income which accounts for −50.71% change. Track more SOMNOMED LTD. financial stats to get the full picture.
No, RJV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RJV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOMNOMED LTD. stock right from TradingView charts — choose your broker and connect to your account.
RJV reached its all-time high on Oct 27, 2016 with the price of 1.745 EUR, and its all-time low was 0.113 EUR and was reached on Apr 10, 2024. View more price dynamics on RJV chart.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on SOMNOMED LTD. future price: according to them, RJV price has a max estimate of 0.14 EUR and a min estimate of 0.14 EUR. Watch RJV chart and read a more detailed SOMNOMED LTD. stock forecast: see what analysts think of SOMNOMED LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOMNOMED LTD. EBITDA is ‪−528.76 K‬ EUR, and current EBITDA margin is 1.25%. See more stats in SOMNOMED LTD. financial statements.